RADIOLABELED LIPOSOMES AS DRUG DELIVERY NANOTHERANOSTICS

about

Development of Biocompatible and Functional Polymeric Nanoparticles for Site-Specific Delivery of Radionuclides.

P2860

Q42581457-943401DF-2D02-4ADE-8DF7-F9A107462C2B

P2860

RADIOLABELED LIPOSOMES AS DRUG DELIVERY NANOTHERANOSTICS

Item

http://www.wikidata.org/entity/Q57832750

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2013

@uk

name

RADIOLABELED LIPOSOMES AS DRUG DELIVERY NANOTHERANOSTICS

@en

RADIOLABELED LIPOSOMES AS DRUG DELIVERY NANOTHERANOSTICS

@nl

type

Item

label

RADIOLABELED LIPOSOMES AS DRUG DELIVERY NANOTHERANOSTICS

@en

RADIOLABELED LIPOSOMES AS DRUG DELIVERY NANOTHERANOSTICS

@nl

prefLabel

RADIOLABELED LIPOSOMES AS DRUG DELIVERY NANOTHERANOSTICS

@en

RADIOLABELED LIPOSOMES AS DRUG DELIVERY NANOTHERANOSTICS

@nl

P1476

RADIOLABELED LIPOSOMES AS DRUG DELIVERY NANOTHERANOSTICS

@en

P2093

Ande Bao

http://www.w3.org/2001/XMLSchema#string

Beth Goins

http://www.w3.org/2001/XMLSchema#string

Keitaro Sou

http://www.w3.org/2001/XMLSchema#string

Shihong Li

http://www.w3.org/2001/XMLSchema#string

William T. Phillips

http://www.w3.org/2001/XMLSchema#string

P2860

Combination radiofrequency ablation and intravenous radiolabeled liposomal Doxorubicin: imaging and quantification of increased drug delivery to tumors.

Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging.

Convection enhanced delivery for treating brain tumors and selected neurological disorders: symposium review.

Fabrication of {198Au0} radioactive composite nanodevices and their use for nanobrachytherapy.

Megakaryopoiesis

The clinical role of fusion imaging using PET, CT, and MR imaging.

An optical and microPET assessment of thermally-sensitive liposome biodistribution in the Met-1 tumor model: Importance of formulation.

Interventional therapy of head and neck cancer with lipid nanoparticle-carried rhenium 186 radionuclide.

A phase I/II study of neoadjuvant liposomal doxorubicin, paclitaxel, and hyperthermia in locally advanced breast cancer.

Do liposomal apoptotic enhancers increase tumor coagulation and end-point survival in percutaneous radiofrequency ablation of tumors in a rat tumor model?

P304

252-267

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/9781118356845.CH11

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P921

drug delivery